SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-10-03 13:54
Tx date 2024-09-27
$CIII
Cytophage Technologies Ltd.
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,900
+10,000 vol
$0.29 each
110,000
Filed 2024-05-06 17:55
Tx date 2024-05-06
$CIII
Cytophage Technologies Ltd.
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$17,000
+50,000 vol
$0.34 each
100,000
Filed 2024-04-19 08:21
Tx date 2024-04-18
$CIII
Cytophage Technologies Ltd.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,600
+4,000 vol
$0.40 each
599,400
Filed 2024-04-17 09:39
Tx date 2024-04-17
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$16,500
+44,000 vol
$0.375 each
85,000
Filed 2024-04-17 09:38
Tx date 2024-04-16
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-7,788
-22,000 vol
$0.354 each
41,000
Filed 2024-04-12 21:59
Tx date 2024-04-12
$CIII
Cytophage Technologies Ltd.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,760
+6,000 vol
$0.46 each
595,400
Filed 2024-03-22 16:15
Tx date 2024-03-22
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$6,142
+13,500 vol
$0.455 each
63,000
Filed 2024-03-19 09:34
Tx date 2024-03-18
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$6,960
+14,500 vol
$0.48 each
49,500
Filed 2024-03-15 16:36
Tx date 2024-03-15
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,076
+16,826 vol
$0.48 each
50,000
Filed 2024-03-15 12:28
Tx date 2024-03-15
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$4,800
+10,000 vol
$0.48 each
35,000
Filed 2024-03-15 11:05
Tx date 2024-03-14
$CIII
Cytophage Technologies Ltd.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,882
+3,900 vol
$0.4826 each
589,400
Filed 2024-03-08 20:19
Tx date 2024-03-07
$CIII
Cytophage Technologies Ltd.
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,494
+3,000 vol
$0.4983 each
585,500
Filed 2024-02-16 12:29
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Kalcevich, Julius John
5 - Senior Officer of Issuer
Holder: 2253549 Ontario Ltd (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
25,000
Filed 2024-02-16 12:28
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
25,000
Filed 2024-02-16 00:07
Tx date 2024-02-15
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$12,915
+31,500 vol
$0.41 each
74,595
Filed 2024-02-16 00:05
Tx date 2024-02-09
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
Common Shares
99 - Correction of information
$12,125
+25,000 vol
$0.485 each
25,000
Filed 2024-02-16 00:02
Tx date 2022-02-01
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: K Chun (R) (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-02-16 00:01
Tx date 2024-02-09
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$12,600
+25,000 vol
$0.50 each
43,095
Filed 2024-02-09 16:47
Tx date 2024-02-09
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$24,825
+50,000 vol
$0.4965 each
Filed 2024-02-14 08:44
Tx date 2024-02-13
$CIII
Cytophage Technologies Ltd.
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,500
+5,000 vol
$0.50 each
5,000
Filed 2024-02-14 08:42
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-02-14 08:41
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-02-14 08:06
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-02-12 17:15
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Theriault, Steven Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
650,000
Filed 2024-02-12 17:13
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Theriault, Steven Serge
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
5,000,000
Filed 2024-02-12 17:11
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Gabor, Robert Thomas
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
350,000
Filed 2024-02-12 17:10
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Gabor, Robert Thomas
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2024-02-12 17:08
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Kodihalli, Shanthamma
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
350,000
Filed 2024-02-12 17:06
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Kodihalli, Shanthamma
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
20,000
Filed 2024-02-12 17:04
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Kodihalli, Shanthamma
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
40,000
Filed 2024-02-12 17:00
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Medwick, Heather Katherine
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2024-02-12 16:58
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Medwick, Heather Katherine
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
450,000
Filed 2024-02-12 16:56
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Hurley, Charles
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
60,000
Filed 2024-02-09 16:47
Tx date 2024-02-09
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$24,825
+50,000 vol
$0.4965 each
68,095
Filed 2024-02-06 17:51
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: Chunkerhead Ltd. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+760,000 vol
868,570
Filed 2024-02-06 17:49
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition

+152,500 vol
273,133
Filed 2024-02-06 17:20
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-531,114 vol
236,441
Filed 2024-02-06 17:20
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-212,445 vol
767,555
Filed 2024-02-06 17:18
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-531,114 vol
Filed 2024-02-06 17:15
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-212,445 vol
Filed 2024-02-06 17:04
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-104,326 vol
33,174
Filed 2024-02-06 17:01
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-379,367 vol
120,633
Filed 2024-02-06 16:59
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: Chunkerhead Ltd. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-341,430 vol
108,570
Filed 2024-02-06 16:57
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Ollerhead, William
4 - Director of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-56,905 vol
18,095
Filed 2024-02-06 15:29
Tx date 2024-02-02
$CIII
Cytophage Technologies Ltd.
Kalcevich, Julius John
5 - Senior Officer of Issuer
Holder: 2253549 Ontario Ltd (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2024-02-06 15:20
Tx date 2024-02-02
$CIII
Cuspis Capital III Ltd.
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
350,000
Filed 2024-02-06 15:19
Tx date 2024-02-02
$CIII
Cuspis Capital III Ltd.
Kalcevich, Julius John
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
50,000
Filed 2024-02-06 10:05
Tx date 2024-02-02
$CIII
Cuspis Capital III Ltd.
Graham, Michael
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2023-05-15 16:09
Tx date 2023-05-15
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,500
+50,000 vol
$0.13 each
137,500
Filed 2023-02-24 13:56
Tx date 2023-02-22
$CIII
Cuspis Capital III Ltd.
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+55,000 vol
755,000
Filed 2023-02-16 11:29
Tx date 2023-02-14
$CIII
Cuspis Capital III Ltd.
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,937
+87,500 vol
$0.125 each
862,500
Filed 2023-02-14 18:18
Tx date 2023-02-14
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$10,937
+87,500 vol
$0.125 each
87,500
Filed 2022-07-15 15:43
Tx date 2022-07-15
$CIII
Cuspis Capital III Ltd.
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,500
+50,000 vol
$0.13 each
775,000
Filed 2022-07-15 12:50
Tx date 2022-07-15
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,500
+50,000 vol
$0.13 each
75,000
Filed 2022-07-11 20:03
Tx date 2022-07-11
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,500
+25,000 vol
$0.14 each
25,000
Filed 2022-07-11 20:00
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (R) (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-07-11 19:59
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: William Ollerhead (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-07-11 18:58
Tx date 2022-07-11
$CIII
Cuspis Capital III Ltd.
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,500
+75,000 vol
$0.14 each
700,000
Filed 2022-07-11 13:37
Tx date 2022-07-11
$CIII
Cuspis Capital III Ltd.
Schoevest Investment Inc.
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,000
+50,000 vol
$0.14 each
950,000
Filed 2022-06-22 09:23
Tx date 2022-06-21
$CIII
Cuspis Capital III Ltd.
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,000
+100,000 vol
$0.14 each
725,000
Filed 2022-02-07 17:35
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+600,000 vol
840,000
Filed 2022-02-07 17:21
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+240,000 vol
240,000
Filed 2022-02-07 17:19
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-07 17:15
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Elliott, C. Fraser
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
625,000
Filed 2022-02-04 12:05
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
840,000
Filed 2022-02-04 12:02
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
McCutcheon, James Grant
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
625,000
Filed 2022-02-03 15:03
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Schoenmakers, Jack Theodorus
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+600,000 vol
840,000
Filed 2022-02-03 15:02
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Schoenmakers, Jack Theodorus
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+240,000 vol
240,000
Filed 2022-02-03 14:51
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Schoenmakers, Jack Theodorus
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-03 14:42
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Schoevest Investment Inc.
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
900,000
Filed 2022-02-03 14:25
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+700,000 vol
980,000
Filed 2022-02-03 14:23
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+280,000 vol
280,000
Filed 2022-02-03 14:16
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-02-03 11:33
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2022-02-03 11:32
Tx date 2022-02-01
$CIII
Cuspis Capital III Ltd.
Ollerhead, William
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Chunkerhead Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
450,000